Compare Tripadvisor Inc Common Stock (TRIP) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tripadvisor Inc Common Stock vs 22nd Century Group Inc — how do they compare? Tripadvisor Inc Common Stock trades at $8.71 (market cap $1.01B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Tripadvisor Inc Common Stock is far larger — about 1624.7× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 3,004,748). Which is the better fit depends on your goals — on Pluang, investors hold Tripadvisor Inc Common Stock for 57 Days and 22nd Century Group Inc for 32 Days on average.
| TRIP | XXII | |
|---|---|---|
Market Cap | $1.01B | $621.67K |
Volume | 3,004,748 | 45,625 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $16.72 | $483.00 |
52-Week Low | $8.04 | $0.80 |
Typical Hold Time | 57 Days | 32 Days |
Enterprise Value | $1.06B | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TripAdvisor (TRIP) trades at $8.69, up 0.7% on the day, but remains near its 52-week low of $8.27 (Defense World, 2026-09-25). The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported Q2 2026 earnings of $0.35 per share, missing the $0.375 estimate (Zacks Investment Research, 2026-08-06), while revenue trends show modest growth from $1.5B in 2022 to $1.9B in 2025. Analyst sentiment is cautious with a consensus price target of $13.58, implying significant upside potential from current levels.
The outlook for TRIP hinges on its ability to stabilize core business performance amid competitive pressures from AI-driven travel platforms. Investment opportunity lies in the discounted valuation relative to analyst targets, but risks include persistent earnings misses, declining net cash flow, and market share erosion. The completion of TheFork subsidiary sale could provide a near-term catalyst, but execution remains key for shareholder value creation.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Tripadvisor Inc Common Stock
TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
